Healios K.K. (HLOSF)
USD 1.35
(0.0%)
USD 1.35
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.69 Billion JPY | -7301.85% |
| 2022 | -4.77 Billion JPY | 18.02% |
| 2021 | -3.39 Billion JPY | -15.66% |
| 2020 | -3.96 Billion JPY | -0.91% |
| 2019 | -4.16 Billion JPY | 99.24% |
| 2018 | -4.98 Billion JPY | -121.76% |
| 2017 | -2.24 Billion JPY | 32.66% |
| 2016 | -3.33 Billion JPY | -44670.01% |
| 2015 | -932.34 Million JPY | 98.41% |
| 2014 | - JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -50 Million JPY | 92.57% |
| 2024 Q1 | -6.43 Million JPY | 37.45% |
| 2023 Q2 | -4.1 Million USD | 26.66% |
| 2023 FY | - JPY | -7301.85% |
| 2023 Q4 | -8.17 Million USD | -83.23% |
| 2023 Q1 | -5.59 Million USD | 25.3% |
| 2023 Q3 | -4.46 Million USD | -8.83% |
| 2022 Q2 | -11.27 Million JPY | 99.16% |
| 2022 Q4 | -7.48 Million JPY | -16.55% |
| 2022 Q3 | -6.42 Million JPY | 43.03% |
| 2022 Q1 | -1.33 Billion JPY | 7.41% |
| 2022 FY | - JPY | 18.02% |
| 2021 FY | - JPY | -15.66% |
| 2021 Q2 | -8.73 Million JPY | 28.06% |
| 2021 Q4 | -1.44 Billion JPY | -5.79% |
| 2021 Q1 | -12.13 Million JPY | 98.97% |
| 2021 Q3 | -1.36 Billion JPY | -15534.81% |
| 2020 Q1 | -895 Million JPY | 28.11% |
| 2020 FY | - JPY | -0.91% |
| 2020 Q3 | -1.02 Billion JPY | -18.34% |
| 2020 Q2 | -867 Million JPY | 3.13% |
| 2020 Q4 | -1.17 Billion JPY | -14.81% |
| 2019 Q4 | -1.24 Billion JPY | -62.75% |
| 2019 Q3 | -765 Million JPY | 22.34% |
| 2019 Q1 | -893 Million JPY | 12.79% |
| 2019 Q2 | -985 Million JPY | -10.3% |
| 2019 FY | - JPY | 99.24% |
| 2018 Q1 | -545 Million JPY | 2.91% |
| 2018 Q3 | -726 Million JPY | 73.71% |
| 2018 Q2 | -2.76 Billion JPY | -406.61% |
| 2018 FY | - JPY | -121.76% |
| 2018 Q4 | -1.02 Billion JPY | -41.05% |
| 2017 Q1 | -519 Million JPY | -62.11% |
| 2017 FY | - JPY | 32.66% |
| 2017 Q2 | 191.65 Million JPY | 136.93% |
| 2017 Q4 | -561.33 Million JPY | 34.59% |
| 2017 Q3 | -858.19 Million JPY | -547.78% |
| 2016 Q2 | -512.27 Million JPY | 75.87% |
| 2016 FY | - JPY | -44670.01% |
| 2016 Q4 | -320.14 Million JPY | 28.06% |
| 2016 Q3 | -445.03 Million JPY | 13.13% |
| 2016 Q1 | -2.12 Billion JPY | -498.21% |
| 2015 Q2 | -280.74 Million JPY | -20.7% |
| 2015 Q4 | -354.94 Million JPY | -61.31% |
| 2015 Q3 | -220.04 Million JPY | 21.62% |
| 2015 Q1 | -232.6 Million JPY | 0.0% |
| 2015 FY | - JPY | 98.41% |
| 2014 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -3698.074% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -45405.843% |
| SQZ Biotechnologies Company | -64.14 Million USD | -4106.358% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -15432.527% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 2969.049% |
| Mesoblast Limited | -62.38 Million USD | -4224.429% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -175545.438% |
| Genus plc | 73.7 Million USD | 3760.787% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -40707.579% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -75964.323% |
| Marizyme, Inc. | -34.28 Million USD | -7770.141% |
| ContraFect Corporation | -64.99 Million USD | -4050.833% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -30656.954% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -59508.567% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -192365.73% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -101925.073% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -116001.936% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -520703.172% |
| Accustem Sciences Inc. | -3.74 Million USD | -71915.437% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -5494.377% |
| EV Biologics, Inc. | -1.26 Million USD | -212821.779% |
| Q BioMed Inc. | -617.62 Thousand USD | -436732.527% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 75631.915% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -426524.668% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -118000.809% |
| Biomind Labs Inc. | -1.03 Million USD | -260689.967% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 27415.987% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -37574.855% |
| Skye Bioscience, Inc. | -13.54 Million USD | -19815.04% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -181288.882% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -10791900.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -69358.747% |
| IMV Inc. | -35.52 Million USD | -7494.995% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -16900.912% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -107735.371% |
| GB Sciences, Inc. | -1.41 Million USD | -189915.389% |
| Alpha Cognition Inc. | -9.7 Million USD | -27698.382% |
| HST Global, Inc. | -5303.00 USD | -50876762.153% |
| CSL Limited | 4.78 Billion USD | 156.337% |
| Halberd Corporation | -74.27 Thousand USD | -3632151.377% |
| Enzolytics Inc. | -2.12 Million USD | -127042.466% |
| Resverlogix Corp. | -11.74 Million USD | -22877.346% |
| Affymax, Inc. | -14.29 Million USD | -18773.733% |
| SYBLEU INC | -141.57 Thousand USD | -1905657.535% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -87983.118% |
| argenx SE | -216.02 Million USD | -1148.941% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -4775.404% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 221792.687% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -179897.945% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 712266.485% |
| AVAX Technologies, Inc. | -6.11 Million USD | -44038.027% |
| Zenith Capital Corp. | -8.6 Million USD | -31250.221% |
| Genscript Biotech Corporation | -248.71 Million USD | -984.756% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -15486955.852% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -110181.75% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -1532642.4% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -6706.796% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -93181.324% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -257758.077% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 40125025.64% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -154071.517% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -140354.191% |
| BioStem Technologies, Inc. | -7.55 Million USD | -35617.855% |
| ONE Bio Corp. | 13.61 Million USD | 19919.226% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -1489783.372% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -131061.886% |
| Agentix Corp. | -1.37 Million USD | -196582.209% |
| LadRx Corporation | 412.28 Thousand USD | 654504.863% |
| Cell Source, Inc. | -4.27 Million USD | -63047.656% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -734607.438% |
| Regen BioPharma, Inc. | 1.46 Million USD | 184143.723% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -287855.908% |
| NovAccess Global Inc. | -1.03 Million USD | -260627.466% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 30572.788% |
| Itoco Inc. | -1.86 Million USD | -144255.656% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -710610.711% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -241656.272% |
| Kadimastem Ltd | -2.62 Million USD | -102705.195% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -1128062.241% |
| CytoDyn Inc. | -18.02 Million USD | -14864.779% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -3413836.656% |
| Mobile Lads Corp. | -2.24 Million USD | -120284.141% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -22062210.9% |
| Qrons Inc. | -40.08 Thousand USD | -6731268.978% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -555412.088% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 511634.166% |
| Rebus Holdings, Inc. | -951 Thousand USD | -283601.367% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -253946.572% |
| International Stem Cell Corporation | 202 Thousand USD | 1335743.564% |
| Bioxytran, Inc. | -3.82 Million USD | -70525.554% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -5125279.939% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -109488.73% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -7421.815% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -5995455.556% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -98439.08% |
| Neutra Corp. | -181.24 Thousand USD | -1488476.363% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -13283.6% |
| PureTech Health plc | -11.62 Million USD | -23104.61% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -13284.518% |
| IXICO plc | -707 Thousand USD | -381512.447% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -35007.352% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -5480.606% |
| CSL Limited | 4.73 Billion USD | 157.004% |
| Cellectis S.A. | -92.63 Million USD | -2812.475% |